Evidence map›Paper›PMID 38572554›Full record

Trial reportHaematologica2024

Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.

Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Sharon D Bledsoe, Naval G Daver, Elias J Jabbour, Tapan M Kadia, Zeev Estrov, Steven M Kornblau, Michael Andreeff and 14 more

Open access · goldAbstract readClinical Trial, Phase IILetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Emerging Therapeutic Approaches for Anemia in Myelofibrosis.Current hematologic malignancy reports · 2025
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Prithviraj BoseThe University of Texas MD Anderson Cancer Center. pbose@mdanderson.org.
Lucia MasarovaThe University of Texas MD Anderson Cancer Center.
Naveen PemmarajuThe University of Texas MD Anderson Cancer Center.
Sharon D BledsoeThe University of Texas MD Anderson Cancer Center.
Naval G DaverThe University of Texas MD Anderson Cancer Center.
Elias J JabbourThe University of Texas MD Anderson Cancer Center.
Tapan M KadiaThe University of Texas MD Anderson Cancer Center.
Zeev EstrovThe University of Texas MD Anderson Cancer Center.
Steven M KornblauThe University of Texas MD Anderson Cancer Center.
Michael AndreeffThe University of Texas MD Anderson Cancer Center.
Nitin JainThe University of Texas MD Anderson Cancer Center.
Jorge E CortesThe University of Texas MD Anderson Cancer Center.
Gautam BorthakurThe University of Texas MD Anderson Cancer Center.
Yesid AlvaradoThe University of Texas MD Anderson Cancer Center.
Mary Ann RichieThe University of Texas MD Anderson Cancer Center.
Mackenzie H DobbinsThe University of Texas MD Anderson Cancer Center.
Selene A McCrackinThe University of Texas MD Anderson Cancer Center.
Lingsha ZhouThe University of Texas MD Anderson Cancer Center.
Sherry A PierceThe University of Texas MD Anderson Cancer Center.
Xuemei WangThe University of Texas MD Anderson Cancer Center.
Allison M PikeThe University of Texas MD Anderson Cancer Center.
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center.
Hagop M KantarjianThe University of Texas MD Anderson Cancer Center.
Srdan VerstovsekThe University of Texas MD Anderson Cancer Center.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaPrimary MyelofibrosisAgedFemaleHumansMaleMiddle AgedRecombinant Fusion ProteinsTreatment OutcomeRecombinant Fusion Proteins

Identifiers

PMID38572554
PMCPMC11290543
OpenAlexW4393948027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.